Hepatocyte growth factor at S phase induces G2 delay through sustained ERK activation

Biochemical and Biophysical Research Communications

Volumn 356, Issue 1, 2007, Pages 300-305

  Park, Yun Yeon ^a   Nam, Hyun Ja ^a   Lee, Jae Ho ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

ERK; G2 delay; Hepatocyte growth factor; S phase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BLOTTING, WESTERN; BUTADIENES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; G2 PHASE; HELA CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOPRECIPITATION; MITOTIC INDEX; NITRILES; S PHASE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 33947098874     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.123     Document Type: Article

References (21)

1. Planas-Silva M.D., and Weinberg R.A. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9 (1997) 768-772
2. Novak B., and Tyson J.J. A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230 (2004) 563-579
3. Jones S.M., and Kazlauskas A. Growth factor-dependent signaling and cell cycle progression. FEBS Lett. 490 (2001) 110-116
4. Kinzel V., Kaszkin M., Blume A., and Richards J. Epidermal growth factor inhibits transiently the progression from G2-phase to mitosis: a receptor-mediated phenomenon in various cells. Cancer Res. 50 (1990) 7932-7936
5. Barth H., Hoffmann I., Klein S., Kaszkin M., Richards J., and Kinzel V. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester. J. Cell. Physiol. 168 (1996) 589-599
6. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122 (1984) 1450-1459
7. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., and Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
8. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4 (2003) 915-925
9. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta 327 (2003) 1-23
10. Breuhahn K., Longerich T., and Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25 (2006) 3787-3800
11. Tate A., Isotani S., Bradley M.J., Sikes R.A., Davis R., Chung L.W., and Edlund M. Met independent hepatocyte growth factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 6 (2006) 197
12. Birchmeier W., Brinkmann V., Niemann C., Meiners S., DiCesare S., Naundorf H., and Sachs M. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found. Symp. 212 (1997) 230-240 discussion 240-246
13. Baek C.M., Jeon S.H., Jang J.J., Lee B.S., and Lee J.H. Transforming variant of Met receptor confers serum independence and anti-apoptotic property and could be involved in the mouse thymic lymphomagenesis. Exp. Mol. Med. 36 (2004) 283-291
14. Pines J., and Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell. Biol. 115 (1991) 1-17
15. Clute P., and Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1 (1999) 82-87
16. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
17. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., and Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59 (1999) 4375-4382
18. Tamemoto H., Kadowaki T., Tobe K., Ueki K., Izumi T., Chatani Y., Kohno M., Kasuga M., Yazaki Y., and Akanuma Y. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267 (1992) 20293-20297
19. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
20. Bitangcol J.C., Chau A.S., Stadnick E., Lohka M.J., Dicken B., and Shibuya E.K. Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts. Mol. Biol. Cell 9 (1998) 451-467
21. Walter S.A., Guadagno T.M., and Ferrell Jr. J.E. Induction of a G2-phase arrest in Xenopus egg extracts by activation of p42 mitogen-activated protein kinase. Mol. Biol. Cell 8 (1997) 2157-2169